OBJECTIVE: To explore the relationship of the Multiple Sclerosis Neuropsychology Questionnaire (MSNQ; [Benedict, R. H. B., Cox, D., Thompson, L. L., Foley, F., Weinstock-Guttman, B., & Munschauer, F. (2004) . Reliable screening for neuropsychological impairment in multiple sclerosis. Multiple Sclerosis, 10, 675-678; Benedict, R. H. B., Munschauer, F., Linn, R., Miller, C., Murphy, E., Foley, F., et al. (2003) . Screening for multiple sclerosis cognitive impairment using a self-administered 15-item questionnaire. Multiple Sclerosis, 9, 95-101]), a self-report screening measure of neuropsychological functioning in multiple sclerosis (MS), with everyday life functioning, neuropsychological functioning, and mood in MS. Additionally, to investigate the validity, sensitivity, and specificity of the MSNQ to predict cognitive impairment in persons with MS. STUDY DESIGN: Cross-sectional, correlational analyses; analyses of sensitivity and specificity. SETTING: Neuropsychology lab-based study with adults from the community including persons with MS (n = 48) and healthy adults (n = 40). MAIN OUTCOME MEASURES: Subjective and objective measures of everyday life functioning, neuropsychological functioning, and mood; ROC curve of MSNQ-Self report and MSNQ-Informant report, sensitivity and specificity of MSNQ-S and MSNQ-I. RESULTS: Correlational analyses indicate the MSNQ-S is significantly correlated with mood and self-reports of functioning, but not with objectively measures daily functioning and to only few neuropsychological tests. The MSNQ-I was not significantly correlated to mood, self-report of daily functioning or objectively measured daily functioning, but was significantly correlated with several measures of neuropsychological functioning. CONCLUSION: The MSNQ-S was not supported as a sensitive screen for neuropsychological impairment in MS. However, the MSNQ-I was supported as a valid and sensitive screen of cognitive impairment in persons with MS, although further research is needed to determine an optimal cutoff score for this measure.
Introduction
Cognitive impairment is observed in approximately 50% of individuals with multiple sclerosis (MS), most often impacting learning, memory, information processing speed, visual spatial skills, and executive functioning (DeLuca, Barbieri-Berger, & Johnson, 1994; DeLuca, Gaudino, Christodoulou, & Engel, 1998; Demaree, Gaudino, DeLuca, & Ricker, 2002; DeSousa, Albert, & Kalman, 2002; Peyser, Rao, Larocca, & Kaplan, 1990; Rao, 2004) . Cognitive impairment has a significant negative impact on everyday activities such as driving, meal preparation, and managing finances, significantly decreasing individual independence (Amato et al., 1995; Amato, Ponziani, Siracusa, & Sorbi, 2001; Klonoff, Clark, Oger, Paty, & Li, 1991; Rao, 2004; Schultheis, Garray, & DeLuca, 2001 ). In addition, cognitive impairment is a major variable in the high unemployment rate observed in persons with MS (Amato et al., 2001; Rao, Leo, Ellington, et al., 1991; Roessler, Rumrill, & Fitzgerald, 2004; Rumrill, Tabor, Hennessey, & Minton, 2000) , which occurs in the lives of approximately 70-80% of persons with MS (Roessler & Rumrill, 2003; Rao, Leo, Bernardin, & Unverzagt, 1991) .
Given both the prevalence and significant negative impact of cognitive impairments on everyday functioning in MS, there is a need for a brief but accurate screening measure of cognitive impairment, especially considering that complete neuropsychological evaluations are often time consuming and expensive. As such, Benedict et al. (2003) developed a self-report instrument called the Multiple Sclerosis Neuropsychology Questionnaire (MSNQ), which includes items that are designed to measure "neuropsychological competence during activities of daily living," (Benedict et al., 2003) in persons with MS. Designed to be time-and cost-effective, the MSNQ screening instrument consists of 15 self-report items that query cognitive functioning in several domains including attention and processing speed, memory, and 'other cognitive functions.' In an initial study of the MSNQ, Benedict et al. (2003) found that the MSNQ self-report form (MSNQ-S) was correlated significantly with measures of depression, but was not correlated with neuropsychological outcomes. In that same study, the informant version of the MSNQ (MSNQ-I) demonstrated the opposite pattern; demonstrating significant correlations with neuropsychological functioning, but not with measures of depression. However, in a second larger, multi-center trial, Benedict and colleagues reported that both the MSNQ-S and the MSNQ-I were significantly correlated with both cognitive functioning and with measures of depression. However, the MSNQ-S was more strongly correlated with measures of depression than with measures of cognition even in the second study.
Benedict and colleagues also investigated the sensitivity and specificity of the MSNQ to correctly detect cognitive impairment in persons with MS. The informant-report version of the MSNQ (MSNQ-I) was found to have sensitivity = .87 and specificity = .84 to classify persons as impaired or not impaired (Benedict et al., 2004) . In contrast, the sensitivity and specificity of the self-report version of the MSNQ was investigated only in the more recent study and were reported as sensitivity = .83 and specificity = .60. However, the authors noted a high rate of false positives (i.e., people classified as cognitively impaired who were not impaired) in persons who had elevated scores on a self-report measure of depression. Thus, the authors concluded that the MSNQ-S was particularly susceptible to the influence of depressive symptomatology. As such, a new classification labeled "affected" was created by the authors, which included any participant with elevated/impaired scores on either measures of depression or neuropsychological functioning. The sensitivity of the MSNQ-S to correctly identify people in this "affected" group was .80 and the specificity was .68. However, as even noted by the authors, this classification led to "ambiguity about the interpretation of elevated self-report MSNQ [scores] . . . which limits applicability," (Benedict et al., 2004, p. 677) .
Oftentimes in clinical studies, everyday functioning has been assessed primarily through patient report and to a lesser extent, reports from an informant. Past research that has been conducted with older adults (Coy, 2000; Sager, Dunham, Schwantes, & Mecum, 1992; Sayers et al., 2004) , persons with systemic lupus erythematosus (Poole, Atanasoff, Pelsor, & Sibbit, 2006) , cardiac patients (Putzke, Williams, Daniel, Bourge, & Boll, 2000) and persons with MS (Goverover, Kalmar, et al., 2005 ) that compared various self-report measures of functional activities with actual performance. Overwhelmingly, these studies did not find significant correlations between subjective and objective measures of functioning across the majority of tasks. These relationships were even weaker when the participants were cognitively impaired or the objective tasks in question were more complex (Sayers et al., 2004; Poole et al., 2006) . Another consideration when using self-reports of objective behavior, like daily functioning, is that such measures may be biased by negative mood, as is seen in self-reports of cognitive functioning (Benedict et al., 2004) . As the MSNQ assesses cognition in the context of everyday functioning, it is necessary to investigate whether self-reports on the MSNQ are significantly related with actual levels of everyday functioning and how mood impacts this relationship.
Although there is a smaller body of research about the relationship of proxy-reports of daily functioning to actual performance, the literature still suggests that such reports correlate poorly with persons' actual functioning (Weinberger, Samsa, Schmader, & Greenberg, 1992; Zanetti, Geroldi, Frisoni, Bianchetti, & Trabucchi, 1999) . However, very little work in this area has been conducted with persons with MS. As the MSNQ-I demonstrated good correlations with cognitive functioning in past studies; it is possible that the informant-report version of this instrument will be a good predictor of daily functioning, particularly compared to the MSNQ-S.
Similarly, a substantial body of literature in a variety of clinical populations has shown that there is often little relationship between self-reports of cognitive functioning and actual cognitive functioning, particularly when people report emotional distress. This lack of relationship has been observed in HIV/AIDS (Rourke, Halman, & Bassel, 1999) , epilepsy (Elixhauser, Leidy, Meador, Means, & Willian, 1999; Piazzini, Canevini, Maggiori, & Canger, 2001; Sawrie et al., 1999) , chronic pain (Roth, Geisser, Theisen-Goodvich, & Dixon, 2005) , chronic fatigue syndrome (Short, McCabe, & Tooley, 2002; Tiersky, Johnson, Lange, Natelson, & DeLuca, 1997) , and MS (Goverover, Chiaravalloti, & DeLuca, 2005; Lovera et al., 2006) . In MS samples, subjective memory complaints have consistently been found to be related to emotional distress, particularly depression and anxiety in MS (Beatty & Monson, 1991; Goverover, Kalmar, et al., 2005; Hoogervorst et al., 2001; Landro, Sletvold, & Celius, 2000; Maor, Olmer, & Mozes, 2001 ), but not to objective measurements of impaired cognition. Therefore, we will further examine the relationship between subjectively and objectively measures cognitive functioning in persons with MS by investigating the relationship between the MSNQ-S and neuropsychological functioning.
The first purpose of the present study was to evaluate the relationship between the MSNQ and actual everyday functional activity. It is hypothesized that the MSNQ-S will significantly predict self-reported daily functioning and depressive symptomatology, but not objectively measured daily functioning. In contrast, it is hypothesized that the MSNQ-I will significantly predict objectively measured daily functioning, but not self-reported daily functioning or depressive symptomatology.
Secondly, the present study sought to replicate previous work with the MSNQ to clarify the relationships between the MSNQ (both self and informant forms), neuropsychological functioning, and depressive symptomatology. To date, the MSNQ has not been validated by any group independent of its authors and therefore merits further evaluation. It is hypothesized that the MSNQ-S will not be supported as a significant predictor of cognitive impairment. In contrast, it is hypothesized that the MSNQ-I will be supported as a significant predictor of cognitive impairment.
Lastly, the current study investigated the sensitivity and specificity of a previously recommended cutoff score on the MSNQ to accurately detect neuropsychological impairment across domains that the MSNQ purports to assess. Furthermore, we determined a cutoff score for both sensitivity and specificity based on the current study sample.
Method

Participants
Participants consisted of 40 healthy controls (HC) and 48 participants with clinically definitive MS as defined by the criteria of Poser, Paty, and Scheinberg (1983) . MS participants were recruited from two neurological and comprehensive care clinics and from the community in New Jersey through distribution of advertisements. Healthy controls were recruited from hospital staff, significant others and family members of MS participants. A healthy control participant was excluded from serving as an informant for a MS participant (and an informant could not serve as a separate healthy control participant) to avoid any confounds in the data. Healthy controls were matched to the MS subjects for age, gender and years of education. Scores of participants with MS were compared to scores of the healthy control group to determine neuropsychological functioning. Individuals with a history of moderate or severe head injury, stroke, seizures, other neurological illnesses, significant psychiatric disturbance, alcohol abuse, or drug abuse, based on a structured psychiatric interview, were excluded from the current study.
Demographic characteristic of the sample are presented in Table 1 . All participants were between the ages of 27 and 56, with a mean age of 45.1 years (S.D. = 9.1) for the MS group and 41.3 years (S.D. = 12.3) for healthy control group. The MS group had an average of 14.7 (S.D. = 2.1) years of education and the healthy control group had an average of 14.9 (S.D. = 2.0) years. Participants were 80% female in the MS group and 70% female in the healthy control group. Of the participants with MS, 61.3% were married and 50% were employed either full-or part-time. Of the healthy control participants, 50.0% were married, and 92.5% were employed either full-or part-time. As expected, significantly more MS participants' employment status was characterized by disability status compared to healthy controls. In the current sample the classifications of MS were as follows: 68.8% relapsing-remitting, 10% primary progressive and 21.2% secondary progressive. MS participants had a mean onset of MS of 14.6 years and an average of 18.5 months since their last exacerbation. Descriptive analyses determined that there were no significant differences in age, education, marital status, or gender between the MS and healthy control (HC) groups.
The relationships of informants in our sample to the participants with MS were as follows: 64.1% spouse or domestic partner, 13.2% were a child of the participant, 9.4% were a parent, 10.7% identified as a friend, and 5.7% were other family relations. On average the participants and informants had known each other for 22.48 years (S.D. = 10.52), with a range of 1 year (a spouse) to 44 years (a parent). The information given by informants for our sample indicates that 68.5% of the informants see the participants daily, 13% see the participants 4-6 times a week, and 18.5% see the participants 1-3 times per week. The EFPT was designed to objectively assess cognitive functioning through actual performance of several increasingly complex tasks. The EFPT includes a total of five tasks: hand washing, simple cooking (cooking oatmeal), telephone use, medication management, and bill paying. In the current study, an additional sixth task, complex cooking, was added as a sixth task (Goverover, Kalmar, et al., 2005) . In the complex cooking task, participants must follow a recipe to make a casserole, which has several additional steps and many more ingredients than the simple cooking task. The examiner observes an individual's performance on these six tasks, noting what, if any, cues or assistance are needed to accurately and safely carry out each task. Cues can be verbal or physical (i.e., use of gestures) and the type and amount of cueing is standardized and is associated with degree and nature of cognitive impairment. Physical inability to complete any aspect of a task is not considered a "failure" for the task, as the EFPT attempts to capture cognitive aspects of performing everyday tasks. Thus, participants were not penalized for requesting physical assistance, as it indicated an awareness of physical limitations and safety risk. For each task, performance is scored on a 0-5 scale based on the level of independence versus cues required when a participant is unable to remember or plan what to do next, with 0 indicating independent performance, 1 point given for verbal guidance, 2 points for physical guidance (i.e., gestures), 3 points for direct verbal assistance, 4 points for assistance with physical contact, and 5 points when the examiner must complete the task for the participant. Each task is scored across five areas including: initiation, organization, sequencing, task completion, and judgment and safety. Both a score for each individual task and a total score (i.e., the sum of cues across the six tasks) were computed. Lower scores indicate greater independence. Higher scores indicate the need for greater assistance to competently complete each task. ; Baum, Edwards, & Morrow-Howell, 1993) The FBP was designed to assess the type and extent of behavioral independence, capabilities, and need for help in clinical populations. The FBP provides self-report information on the capacity to engage in everyday tasks, social interactions, and problem solving. There are two forms of the assessment, one of which is completed by the patient and the other of which is completed by an "informant" (e.g., spouse, friend, son, daughter, etc.). For each of the 27 items, a participant or informant rates the functional behavior of the participant on a 5-point Likert-type scale. Scores on the FBP can range from 0 (indicating significant troubles with functional behavior) to 108 (indicating no problems related to functional behavior). Beck, 1987) The BDI is a 21-item self-report test that measures the presence and severity of depressive symptomatology. Each of the items assesses a specific symptom or attitude which reflects the psychiatric definition and description of depression and a total score is calculated.
Test instruments
Executive functioning performance test (EFPT;
The functional behavior profile (FBP; self and informant forms
Measure of mood
Beck Depression Inventory (BDI;
Neuropsychological tests
A battery of commonly utilized validated neuropsychological measures was utilized to assess cognition. The Wide Range Achievement Test-3, reading subtest (WRAT-3; Wilkinson, 1993) was used to provide an estimate of pre-morbid functioning. Attention and processing speed were assessed using the WAIS-R Digit Span and Symbol Search subtests (Wechsler, 1981) as well as a modified oral version of the Symbol Digit Modalities Test (SDMT) (Rao, Leo, Ellington, et al., 1991; Smith, 1991) . Verbal memory was assessed with Logical Memory I and II of the WMS-III (Wechsler, 1997) and working memory was assessed utilizing the Paced Auditory Serial Addition Task (PASAT; Rao, Leo, Ellington, et al., 1991) and the WAIS-R Digit Span Backwards (Wechsler, 1981) . Verbal learning was assessed using a modified Selective Reminding Task on which participants have to learn a list of words and are reminded only of the words they did not recall on each trial until they reach a set learning criterion or complete 15 trials (modified Selective Reminding Test (mSRT); Buschke, 1973; DeLuca et al., 1998) . Executive functioning assessments included the Stroop Color-Word test (Golden, 1978) , the Wisconsin Cart Sort Test (WCST; Heaton, Chelune, Talley, Katy, & Curtiss, 1993) and the Controlled Oral Word Association Test (COWAT; Spreen & Strauss, 1991) . Visual spatial abilities were assessed with the Judgment of Line Orientation test (JOLO; Benton, Sivan, Hamsher, Varney, & Spreen, 1994) .
Cognitive domain scores
Cognitive domain scores were created to reflect the areas of neuropsychological functioning that Benedict et al. (2003) asserted were assessed by the MSNQ. The cognitive domain scores were used to operationalize cognitively impaired versus not cognitively impaired groups for the current study (described in more detail below). Neuropsychological assessments were classified into categories based on the domains they are purported to evaluate per Lezak, Howieson, and Loring (2004) and Strauss, Sherman, and Spreen (2006) .
Processing speed and attention
The WAIS-III Digit Symbol and Symbol Search subtests (which comprise the Processing Speed Index of the WAIS-III) were utilized to represent the domains of processing speed and attention.
Memory
This domain score was created by averaging the standardized scores of LM I and II of the WMS-R. Although the LM I and LM II assess immediate and delayed memory, respectively, the two types of memory were collapsed in the present study due to the significant overlap of persons who were impaired on both (and the lack of persons who were impaired on only one of these subtests).
Of the domains that the MSNQ assesses, Benedict et al. (2003) labeled a final cognitive category as "other cognitive skills." The current authors included working memory and executive functioning, as items in the MSNQ query about everyday functioning that would require skills in these two domains.
Working memory
This domain score was created derived from the total score on the PASAT, a test of working memory and the Digit Span Backwards subtest (Lezak et al., 2004) .
Executive functioning
This domain score was created by averaging the standardized scores of the Stroop Color-Word test, WCST Perseverative Errors, and a fluency test (COWAT).
A "global" impairment score was created. Following the same criterion as Benedict et al. (2003) , participants' scores on neuropsychological tests were classified as either "impaired" (performing at less than 5th percentile) or "not impaired" (defined as scores that were above the 5th percentile). Each person with at least one cognitive domain score that was less than the 5th percentile was classified into a cognitive impairment group.
Procedure
Potential participants were screened via telephone to determine if they met criteria for study inclusion. If the participant met the inclusion criteria they were invited to participate in the study and scheduled for an interview and testing. All participants signed a consent form approved by the Institutional Review Board prior to their participation in the study. Testing was performed in two sessions. In the first session, which lasted approximately 3-5 h, participants completed a neuropsychological battery and the questionnaires regarding mood, quality of life, daily functioning, and their illness. In the second session, which lasted between 1 and 2 h, participants were administered any remaining self-report questionnaires (if needed) and the EFPT, the objective measure of daily functioning.
Data analysis
Descriptive analyses were performed to characterize the study participants. A correlation matrix was created including depressive symptomatology (BDI total score), neuropsychological assessment scores, MSNQ(-S and -I) scores, a score for self-report of daily functioning (FBP) and a score for the objective measure of daily functioning (EFPT) linear regressions were performed to assess whether the MSNQ (both self-report and informant versions) significantly predicted daily functioning (subjectively and objectively measured), as stated in the study hypotheses. Age, years of education and EDSS score (a measure of disability commonly used in MS), were entered into the first step of the equation to control for their potential confounding predictive value for the targeted outcomes.
Logistic regressions were conducted to determine the value of the MSNQ-S and the MSNQ-I to predict the classification of individuals as cognitively impaired or not impaired.
Analyses were conducted to test the sensitivity and specificity of the MSNQ-I, to classify individuals as cognitively impaired versus not impaired. The recommended scores previously asserted by Benedict et al. (2004) to maximally separate cognitively impaired persons from non-impaired persons were 22 or greater on the MSNQ-I and 24 or greater for the MSNQ-S. These scores were investigated in our sample to determine the sensitivity and specificity of the MSNQ-S and MSNQ-I to classify people as impaired or not impaired for a global cognitive functioning score. Lastly, a receiver operating characteristic (ROC) analysis was performed to determine the cutoff score that would maximize sensitivity and specificity to classify persons as cognitively impaired in the current study sample. 
Results
Neuropsychological functioning and MSNQ scores in MS versus healthy controls
There were significant differences between the healthy control and MS groups for scores in all neuropsychological domains (attention/processing speed, memory, working memory and executive functioning), with the MS group scoring significantly lower than the healthy control group (all p's < .01). There were also significant differences between the healthy control and MS groups on 11 of the neuropsychological tests administered (all p's < .05; see Table 2 ). There were no significant differences between the groups on the WRAT-3 reading subtest (and estimate of pre-morbid intelligence), a verbal fluency task, and a learning score on a Selective Reminding Test (p > .05).
There was a significant difference between the healthy control group (M = 12.41, S.D. = 6.85) and MS group (M = 23.35, S.D. = 11.19) on the MSNQ-S, with significantly more problems reported by persons in the MS group (F(1, 80) = 25.65, p < .01). There was also a significant difference between the healthy control group (M = 8.47, S.D. = 7.81) and the MS group (M = 19.35, S.D. = 12.73) on the MSNQ-I, with significantly more problems reported by the informants of the MS group than informants of the healthy control group (F(1, 68) = 17.06, p < .01). Tables 2 and 3) A correlation matrix was constructed to determine the relationships between the MSNQ (both versions) and neuropsychological functioning, mood, and everyday functioning. The MSNQ-I demonstrated significant correlations with several neuropsychological assessments including the PASAT, Stroop Color-Word test, the SDMT, the JOLO, the mSRT and the WAIS-R Processing Speed Index (see Table 2 ). In contrast, the MSNQ-S demonstrated significant correlations with only two neuropsychological assessments; the mSRT and the JOLO. As was seen in Benedict et al.'s previous studies, the MSNQ-S was significantly positively correlated to scores on the Beck Depression Inventory (r = .42, p < .01), meaning that higher self-reports of depressive symptomatology were related to self-reports of more significant cognitive impairment. In contrast, the MSNQ-I was not significantly correlated to the BDI (all p's < .05; see Table 2 ).
Relationship of the MSNQ with neuropsychological functioning, mood, and daily functioning (see
The MSNQ-S was significantly correlated with a timed 25-ft walk (r = −.38, p < .05), but the MSNQ-I was not. Neither MSNQ score was correlated with age, education, or EDSS score (a common measure of disability in MS). However, as age and education are particularly important variables when discussing neuropsychological and functional outcomes in MS, they were included in the first step of all regression analyses in the current study to account for any potential confounding effect they may have with the study outcome variables. EDSS was not included as a control variable for two reasons: (1) it was not correlated with either MSNQ measure and (2) the researchers were replicating part of the work of Benedict et al. (2003 Benedict et al. ( , 2004 , who did not include the EDSS as a control variable in their analyses.
Depressive symptomatology in relation to subjective and objective measures of functioning
A similar pattern was observed for the effect of mood on measures of daily functioning as was seen with neuropsychological functioning (see Table 3 ). Results indicated that the BDI total score was significantly negatively correlated with subjective or self-reports of daily functioning as measured by the FBP (r = −.44, p < .05), indicating that those with higher levels of depressive symptomatology reported less independence and greater need for help in their daily activities (see Table 3 ) In contrast, the BDI total score was not significantly correlated with objective measurement of daily functioning as measured by the EFPT (r = −.01, p > .05) nor was it correlated with any of the individual EFPT tasks (all p's > .05). Therefore, greater depressive symptomatology was not related to actual objectively measured performance of tasks of daily functioning similarly to how depressive symptomatology was not related to actual objectively measured neuropsychological functioning. Rather, the BDI was correlated with subjective or self-report assessment of daily activities.
As a result of these analyses, BDI score was not included in any subsequent analyses in which neuropsychological functioning or objectively measured everyday functioning were the outcomes to be predicted.
Value of the MSNQ to predict objectively measured everyday functioning (see Tables 4 and 5)
After controlling for age and education, the MSNQ-S only accounted for an additional 1.0% of the variance in EFPT score, which was not significant. The same regression equation was run with the MSNQ-I. Again, age, and education were controlled for in the first step. In the second step, the MSNQ-I predicted an additional 2.8% of the variance in EFPT scores, which was not significant. All p > .05. Table 6 Value of MSNQ-S and BDI to predict subjectively measured daily functioning (n = 47)
Step 
Value of MSNQ and mood in predicting self-reported daily functioning
After controlling for age and education, the MSNQ-S and BDI total scores were entered simultaneously in the second step (see Table 6 ). These two variables accounted for an additional 35.6% in the variance in FBP self-report score. Both the MSNQ-S and BDI significantly predicted subjectively measured daily functioning (FBP; p < .05) in the final step of the equation. This same regression model was run with the MSNQ-I (see Table 7 ). In the first step of the regression, EDSS, age, and education were controlled for. In the second step, MSNQ-I and BDI total score accounted for an additional 32.2% Table 7 Value of MSNQ-I and BDI to predict subjectively measured daily functioning (n = 39)
Step of the variance in FBP score (p < .05). In the final step of this model, both the BDI and the MSNQ-I were significant predictors of self-reported daily functioning (FBP; both p < .05).
MSNQ and neuropsychological functioning
Logistic regression models were run to determine the predictive value of the MSNQ-S and MSNQ-I to predict classification into cognitively impaired or not impaired groups. In the first regression that investigated the MSNQ-S, the Hosmer and Lemeshow test statistic was not significant, indicating the data was a good fit to the model (p = .52). An odds ratio of 1.05 indicated that an increase in 1 unit in MSNQ-S score would increase the predicted log odds of cognitive impairment by only 5.0%. The overall Chi Square statistic for the model was not significant (χ 2 = 2.85, p > .05; see Table 8 for logistic statistics).
The second regression analyzed the MSNQ-I. In this model, the Hosmer and Lemeshow test statistic was not significant, indicating the data was a good fit to the model (p = .09). An odds ratio of 1.065 indicated that an increase in 1 unit in MSNQ-I score would increase the predicted log odds of cognitive impairment by 6.5%. The overall Chi Square statistic for the model was significant (χ 2 = 5.37, p < .05; see Table 9 for logistic statistics).
Sensitivity and specificity of the MSNQ-I
Following the same methodology as Benedict et al. (2003) , participants scores on neuropsychological tests were classified as either "impaired" (performing at less than 5th percentile based on cognitive domain scores) or "not impaired" (defined as scores that were above the 5th percentile). Benedict et al. (2004) previously designated scores of 22 on the MSNQ-I and 24 on the MSNQ-S as the scores that resulted in the maximum separation between the cognitively impaired versus non-impaired persons. As such, these same designated cutoffs were used to investigate the sensitivity and specificity of the MSNQ measures to classify persons as cognitively impaired or non-impaired. Probabilities were calculated to determine the sensitivity and specificity of the MSNQ-I. Sensitivity is the "true positive" rate, meaning a cognitive impairment predicted by the MSNQ-I was reflected by impaired neuropsychological functioning. Specificity Table 9 Logistic regression analysis of classification of cognitive impairment by the MSNQ-I is the "true negative" rate, meaning that if the MSNQ-I did not predict a cognitive impairment, none existed. As did Benedict et al. (2004) we also calculated positive predictive power (PPV-probability of cognitive impairment in those with MSNQ scores above cutoff) and negative predictive power (NPP-probability of no cognitive impairment among people with MSNQ score below cutoff score).
Each person with at least one cognitive domain score that was less than the 5th percentile was classified into a cognitive impairment group. This criterion was somewhat more liberal than that utilized by Benedict et al. to allow for greater latitude in comparing our sample to the previously studied samples in his studies. Sensitivity and specificity of the MSNQ-S and MSNQ-I to correctly characterize persons in this global impairment category was investigated (see Tables 10 and 11 ). The MSNQ-S demonstrated sensitivity = .52 (95% Confidence Interval (CI) .32-.72) and specificity = .70 (95% CI .51-.82; see Table 10 ) when characterizing persons in the global cognitive impairment categories, utilizing the recommended cutoff score of 24. The sensitivity of the MSNQ-S in the current study, even within the 95% CI, was lower than the sensitivity of .83 reported by Benedict et al. (2004) for this measure. With a cutoff score of 24 on the MSNQ-S, only 62.5% of the MS sample was correctly classified as either impaired or not impaired. The MSNQ-I demonstrated sensitivity of .66 (95% CI .44-.84) and specificity of .77 (95% CI .56-.89; see Table 11 ) when characterizing persons in the global cognitive impairment category, using the aforementioned cutoff score of 22 on the MSNQ-I. Both of these were within a 95% CI of the sensitivity (.87) and specificity (.84) reported by Benedict et al. (2004) for this measure, by a slim margin. A cutoff score of 22 on the MSNQ-I resulted in 70% of the MS sample correctly classified as either impaired or not impaired.
A ROC curve analysis (Metz, 1978; Zweig & Campbell, 1993 ) was conducted to determine, for the current study sample, what cutoff scores would maximize sensitivity and specificity for categorizing persons as cognitively impaired versus not impaired. The area under the ROC curve is a measure of how well a parameter, in this case the MSNQ-S and MSNQ-I, can distinguish between two specified groups (i.e., cognitively impaired versus not impaired). For the MSNQ-Self report, the area under the ROC curve is .62 (S.E. = .09, p > .05; see Fig. 1 ). This means that a randomly selected individual from the cognitively impaired group has a test value larger than that for a randomly chosen individual from the non-impaired group 62% of the time (Zweig & Campbell, 1993) . This value was not significant, indicating that the area under the curve is not significantly different from the area above it, or in other words, the MSNQ-S did not significantly differentiate between these two diagnostic groups. In the current study, a score of 7.50 on the MSNQ-S produced the maximum sensitivity (.90) and specificity (.96) for this measure. Utilizing a score of 8 (note: a score of 8 was used in the analysis, as the MSNQ does not score in half-units) as a cutoff for "impairment" results in correct classification of 90.5% of persons with cognitive impairments in the cognitively impaired group. However, this conservative approach to sensitivity results in a significant number of false positives (persons who are not impaired with scores above the "impaired cutoff" on the MSNQ-S) and decreased specificity.
The ROC analysis for the MSNQ-I resulted in an area under the curve of .74 (S.E. = .08, p > .05; see Fig. 2 ). This means that a randomly selected individual from the cognitively impaired group has a test value larger than that for a randomly chosen individual from the non-impaired group 74% of the time (Zweig & Campbell, 1993) . Although better than the self-report version, this again did not provide strong support for the ability of the MSNQ-I to differentiate between the cognitively impaired and non-impaired groups. In the current study, a score of 10 on the MSNQ-I produced the maximum sensitivity (.94) and specificity (.55) for this measure.
Discussion
The current study was designed to examine how well the MSNQ (self and informant report versions) predict daily functioning and neuropsychological functioning in persons with MS. Additionally, the study evaluated the sensitivity and specificity of both versions of the MSNQ to classify persons as cognitively impaired versus not impaired. The relationships between emotional functioning and subjective and objective measures of cognition and daily functioning were also investigated. The current study was the first that evaluated the psychometric properties and predictive value of the MSNQ for daily functioning and cognitive functioning outside of the group that developed this measure.
Results showed that the MSNQ-S was significantly correlated to self-reported depressive symptomatology and self-reported daily functioning. However, the MSNQ-S did not demonstrate significant correlations with objectively measured daily functioning or objectively measured neuropsychological functioning (except for one measure of learning and one of visual spatial judgment). The current study did not support the sensitivity of the MSNQ-S to classify persons as cognitively impaired versus not impaired.
Results showed that the MSNQ-I appears to be a useful screening measure for cognitive impairment in persons with MS. It significantly correlated with several neuropsychological measures of working memory, learning and memory, executive functioning, and visual spatial judgment. A logistic regression provided modest support for the MSNQ-I's ability to predict impairment classification and analyses of sensitivity and specificity confirm Benedict et al.'s (2004) positive results in this area, within a 95% confidence interval. Although there is support for the MSNQ-I as a screening instrument; it should be used to trigger a neuropsychological evaluation and should not be used as a substitute for such an evaluation.
Importantly, as a person experiences more emotional distress, he or she is increasingly likely to report problems in many areas, including cognition, and pay greater attention to negative information (e.g., Beck, Rush, Shaw, & Emery, 1979; Bruce & Arnett, 2004) . However, oftentimes when behavior is objectively measured in persons with significant depressive symptomatology, it is not as problematic as subjectively described by the distressed individual (e.g., Goverover, Kalmar, et al., 2005) . As the lifetime rate of major depressive disorder in MS is estimated at 50% (and as this estimate does not take subclinical depression into account; Goldman Consensus Group, 2005) , it is important to consider the potential impact of depressive symptomatology on the outcomes of self-report measures of cognition used in MS samples. In the current study, informants were not screened for depression. However, past studies of persons with Alzheimer's disease and their caregivers suggests that depression in the patient has a significant impact on levels of depression in caregivers (e.g., Teri, 1997) . Although it is not known exactly how such depression will impact proxy-reports, it is possible that depression in informants may impact their response patterns and may be an important factor to measure and analyze in future studies.
Consistent with the body of research on depression and self-report outcomes, Benedict et al. (2004) noted that many of the false positive results on the MSNQ-S in their sample were from people who reported significant levels of depressive symptomatology. As such, they created a new outcome category that they labeled as, "affected." This "affected" group included persons with either a cognitive impairment or significant emotional distress. The researchers then found that the MSNQ-S was sensitive and specific in classifying people in this new "affected" category. However, as even the authors noted, classification into such a nebulous category may create more questions than it answers. An elevated score on the MSNQ-S can indeed alert a clinician that a person with MS feels he or she is experiencing a problem in mood or cognition, both of which are often problematic for persons with MS and important to assess. However, an elevated score on the MSNQ-S cannot suggest a differential follow-up for neuropsychological testing versus a diagnostic interview for a mood disorder. The "affected" classification category also moves the MSNQ away from its original intent as a screen of, "neuropsychological competence during activities of daily living," (Benedict et al., 2003) in persons with MS.
The authors of the MSNQ also investigated "cutoff" scores that were found to maximize the separation between cognitively impaired and non-impaired individuals. When the recommended cutoff scores were evaluated in the current study, the MSNQ-S fell short of the previously reported level of sensitivity, even within a 95% confidence interval (CI).
However, within a confidence 95% CI, the cutoff score previously recommended by Benedict et al. for the MSNQ-I was found sensitive and specific. In the current study, much lower scores on the MSNQ-S and -I were supported as the most sensitive and specific 'cutoff' scores.
Of note, although it is helpful and to a point, necessary, to denote a 'cutoff' score at which to classify someone in the cognitively impaired category on a screening tool, such studies require careful consideration of study design (e.g., case-control, cohort) as well as consideration of desirable operating characteristics to determine appropriate sample size (Alonzo, Pepe, & Moskowitz, 2002) . Although adequately powered, none of the studies of the MSNQ (including the current study) have been conducted with the large numbers usually seen for such analyses. As such, a limitation of this and previous studies of the MSNQ, is the variability in what is designated as a "cutoff score" to indicate possible cognitive impairment. Further investigation with larger samples will help to better answer this point. Also of note, in the current study the MSNQ was screening for impairment that was found in only 16/48 of the MS participants. Future studies of the utility of the MSNQ would benefit from including a sample with either a greater number of impaired persons or persons with more severe impairments. Another limitation of the current study is the use of the EFPT. The EFPT is an objective measure of daily activity that has been supported as a sensitive in assessing difficulties in everyday tasks (Goverover, Kalmar, et al., 2005) . However, it was originally designed to measure cognitive functioning during daily tasks in persons with dementia . Therefore, the tasks that it assesses may not present significant enough challenges to persons with MS, although it has been shown to be sensitive relative to healthy controls (Goverover, Kalmar, et al., 2005) . In future studies of everyday functioning in persons with MS, an objective measure with more challenging tasks of everyday functioning may better elucidate the relationships between self-report, mood, and everyday functioning for this population.
Conclusions
The many significant differences on the neuropsychological tests and informant-reports of functioning between the MS group and healthy control group underscore the problems that exist in the MS group and the need to screen for such problems. The MSNQ self and informant versions were originally designed as a screening tools for cognitive impairment in persons with MS. Neither version of the MSNQ was supported as a useful screen for impairment in objectively measured everyday functioning. The current study does not support the use of the MSNQ-S as a valid or sensitive screen for cognitive impairment in persons with MS. Although the MSNQ-S may be a useful screen for identifying persons with cognitive impairment or emotional distress, it cannot identify which of these two elements the MSNQ is assessing at the individual level. However, the MSNQ-I shows some promise as an initial screening measure for potential cognitive impairment in MS, distinctly from psychosocial functioning. As such, the present study provides support for the informant version of the MSNQ as a useful screening tool (not diagnostic tool) for possible cognitive impairment in persons with MS. However, the current authors echo the caution of the original MSNQ authors that the MSNQ is not meant to diagnose cognitive impairment or to take the place of neuropsychological assessment. Rather, the current results support the use of the MSNQ-I as a screening measure that may be used to recommend follow-up neuropsychological testing when appropriate. Therefore, although the MSNQ-S did not prove a good screen for cognitive impairment in MS, the current study supports the MSNQ-I as a good option for a brief, cost-effective screen of cognitive functioning in MS in a valid and sensitive manner.
